Protective effect of phenobarbitone against fulvine-induced hepatic damage and hypertensive pulmonary vascular disease in the rat.
D000818:Animals; D001794:Blood Pressure; D006332:Cardiomegaly / Q000209:etiology; D056486:Chemical and Drug Induced Liver Injury; D005260:Female; D006352:Heart Ventricles; D006976:Hypertension, Pulmonary / Q000139:chemically induced / Q000517:prevention & control*; D008099:Liver / Q000473:pathology; D008107:Liver Diseases / Q000473:pathology / Q000517:prevention & control*; D008168:Lung / Q000473:pathology; D009206:Myocardium / Q000473:pathology; D010634:Phenobarbital / Q000627:therapeutic use*; D010996:Pleural Effusion / Q000473:pathology; D011650:Pulmonary Alveoli / Q000473:pathology; D011651:Pulmonary Artery / Q000473:pathology; D011763:Pyrrolizidine Alkaloids; D051381:Rats
D011763:Pyrrolizidine Alkaloids; D010634:Phenobarbital